🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 13 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 29/08/2017 | 76,87 | 79,51 | 76,80 | 79,16 | +2,17% | 3,53% | 436.818 |
| 28/08/2017 | 77,75 | 78,23 | 76,93 | 77,47 | +0,11% | 1,67% | 407.964 |
| 25/08/2017 | 79,29 | 79,29 | 77,25 | 77,39 | -2,20% | 2,57% | 308.898 |
| 24/08/2017 | 79,43 | 79,43 | 78,13 | 79,13 | -0,03% | 1,63% | 334.386 |
| 23/08/2017 | 79,54 | 80,04 | 78,96 | 79,15 | -0,85% | 1,36% | 272.510 |
| 22/08/2017 | 79,38 | 79,97 | 78,70 | 79,83 | +1,12% | 1,60% | 290.784 |
| 21/08/2017 | 78,71 | 79,53 | 78,24 | 78,95 | +0,23% | 1,64% | 238.687 |
| 18/08/2017 | 78,55 | 79,18 | 77,99 | 78,76 | -0,28% | 1,52% | 277.159 |
| 17/08/2017 | 79,22 | 80,29 | 78,84 | 78,99 | -0,72% | 1,83% | 536.684 |
| 16/08/2017 | 79,35 | 79,98 | 79,00 | 79,56 | +0,41% | 1,23% | 243.656 |
| 15/08/2017 | 79,23 | 79,71 | 78,70 | 79,24 | +0,08% | 1,28% | 296.395 |
| 14/08/2017 | 78,60 | 79,89 | 78,06 | 79,18 | +1,44% | 2,33% | 556.401 |
| 11/08/2017 | 78,04 | 78,53 | 76,40 | 78,05 | +0,11% | 2,73% | 415.177 |
| 10/08/2017 | 78,61 | 79,26 | 77,82 | 77,97 | -1,57% | 1,84% | 422.711 |
| 09/08/2017 | 79,92 | 80,42 | 78,42 | 79,21 | -1,55% | 2,51% | 916.115 |
| 08/08/2017 | 77,98 | 81,06 | 77,92 | 80,46 | +5,86% | 4,03% | 1.463.058 |
| 07/08/2017 | 76,16 | 76,86 | 75,62 | 76,00 | -0,19% | 1,62% | 360.034 |
| 04/08/2017 | 76,28 | 76,48 | 75,03 | 76,14 | +0,16% | 1,90% | 213.199 |
| 03/08/2017 | 75,78 | 76,56 | 75,03 | 76,03 | +0,40% | 2,01% | 148.278 |
| 02/08/2017 | 75,91 | 76,23 | 75,07 | 75,72 | -0,16% | 1,52% | 146.514 |
| 01/08/2017 | 75,78 | 76,04 | 74,58 | 75,85 | +0,55% | 1,93% | 252.152 |
| 31/07/2017 | 75,47 | 75,93 | 73,89 | 75,43 | -0,29% | 2,71% | 182.101 |
| 28/07/2017 | 75,58 | 76,16 | 75,08 | 75,65 | -0,32% | 1,43% | 150.522 |
| 27/07/2017 | 77,22 | 77,24 | 75,11 | 75,89 | -1,53% | 2,75% | 262.091 |
| 26/07/2017 | 77,09 | 77,59 | 76,28 | 77,07 | +0,19% | 1,70% | 205.665 |
| 25/07/2017 | 77,57 | 77,75 | 76,33 | 76,92 | -0,36% | 1,84% | 377.186 |
| 24/07/2017 | 76,95 | 77,79 | 76,15 | 77,19 | +0,56% | 2,13% | 364.041 |
| 21/07/2017 | 75,92 | 76,81 | 74,93 | 76,76 | +1,96% | 2,48% | 352.660 |
| 20/07/2017 | 75,27 | 76,49 | 74,38 | 75,29 | +0,17% | 2,81% | 323.005 |
| 19/07/2017 | 72,96 | 75,36 | 72,73 | 75,17 | +3,16% | 3,60% | 408.765 |